Mirae Asset Global ETFs Holdings’s Cullinan Oncology CGEM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$649K	Buy	35,535 +5,384	+18%	+$80K	﹤0.01%	1863
2026 Q1	$425K	Buy	30,151 +1,492	+5%	+$19.2K	﹤0.01%	1967
2025 Q4	$295K	Buy	28,659 +2,671	+10%	+$24.1K	﹤0.01%	2162
2025 Q3	$154K	Sell	25,988 -3,866	-13%	-$28.3K	﹤0.01%	2461
2025 Q2	$225K	Sell	29,854 -3,465	-10%	-$27.8K	﹤0.01%	2216
2025 Q1	$253K	Buy	33,319 +336	+1%	+$3.22K	﹤0.01%	2195
2024 Q4	$402K	Buy	32,983 +173	+0.5%	+$2.49K	﹤0.01%	2031
2024 Q3	$551K	Buy	32,810 +15,854	+94%	+$281K	﹤0.01%	1869
2024 Q2	$294K	Buy	+16,956	New	+$361K	﹤0.01%	2079

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CGEM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Cullinan Oncology (CGEM) stake by 18% in Q2 2026, buying an estimated $80K and bringing the position to 35,535 shares worth $649K. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

Mirae Asset Global ETFs Holdings first reported a position in CGEM in Q2 2024 and has held it in 9 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

Mirae Asset Global ETFs Holdings held 35,535 shares of Cullinan Oncology worth $649K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 5,384 Cullinan Oncology shares in Q2 2026, an estimated $80K.
Cullinan Oncology made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1863 holding.
Mirae Asset Global ETFs Holdings first reported a position in Cullinan Oncology in Q2 2024 and has held it in 9 quarters since.
183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.